RNAZ · Transcode Therapeutics, Inc. · Documents
$1.75
+0.05 (+2.94%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to the Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming available.”View the 10-Q filed Aug 14, 2026
Market Cap
$28.78M
Shares
16.93M
Volume · Oct 20
6487
Avg daily vol (3M)
53.32K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-10-01 | — | |
| 8-K | — | 2026-09-28 | — | |
| 8-K | — | 2026-09-11 | 2026-09-09 | |
| 10-Q | — | 2026-08-14 | 2026-06-30 | |
| 8-K | — | 2026-08-03 | — | |
| 8-K | — | 2026-07-20 | — | |
| 8-K | — | 2026-07-17 | 2026-07-16 | |
| DEFA14A | — | 2026-07-17 | — | |
| 8-K | — | 2026-07-02 | — | |
| 8-K | — | 2026-06-18 | — | |
| 8-K | — | 2026-06-03 | — | |
| ARS | — | 2026-06-02 | 2025-12-31 | |
| DEF 14A | — | 2026-06-02 | 2026-07-02 | |
| 8-K | — | 2026-06-01 | 2026-05-29 | |
| DEFA14A | — | 2026-05-26 | — | |
| 8-K/A | — | 2026-05-26 | 2026-05-19 | |
| 8-K | — | 2026-05-22 | 2026-05-19 | |
| 10-Q | — | 2026-05-15 | 2026-03-31 | |
| PRE 14A | — | 2026-05-08 | — | |
| S-1 | — | 2026-05-01 | — | |
| S-3 | — | 2026-04-30 | — | |
| 10-K/A | — | 2026-04-30 | 2025-12-31 | |
| 10-K | — | 2026-04-15 | 2025-12-31 | |
| 8-K | — | 2026-04-07 | 2026-04-06 | |
| DEFA14A | — | 2026-04-07 | — | |
| NT 10-K | — | 2026-03-31 | 2025-12-31 | |
| 8-K | — | 2026-03-03 | 2026-03-02 | |
| DEFA14A | — | 2026-03-03 | — | |
| 8-K | — | 2026-02-23 | — | |
| 8-K | — | 2026-02-05 | — | |
| 8-K | — | 2026-01-06 | — | |
| 8-K/A | — | 2025-12-23 | 2025-10-08 | |
| DEFA14A | — | 2025-12-23 | — | |
| 8-K | — | 2025-12-22 | 2025-12-19 | |
| S-3 | — | 2025-12-12 | — | |
| 8-K | — | 2025-12-11 | — | |
| 10-Q | — | 2025-11-14 | 2025-09-30 | |
| 8-K | — | 2025-10-27 | — | |
| DEFA14A | — | 2025-10-27 | — | |
| 8-K/A | — | 2025-10-17 | 2025-10-08 | |
| DEFA14A | — | 2025-10-17 | — | |
| 8-K | — | 2025-10-14 | 2025-10-13 | |
| DEFA14A | — | 2025-10-08 | — | |
| 8-K/A | — | 2025-10-08 | — | |
| DEFA14A | — | 2025-10-08 | — | |
| 8-K | — | 2025-10-08 | — | |
| 8-K | — | 2025-10-03 | 2025-09-30 | |
| 8-K | — | 2025-09-02 | 2025-08-29 | |
| 10-Q | — | 2025-08-14 | 2025-06-30 | |
| DEF 14A | — | 2025-07-15 | 2025-08-29 |
Showing 1–50 of 174 filings